BiotechTubeBiotechTube
COUNTRIES
🇯🇵

Japan

Asia Pacific

Japan is Asia's most mature biotech market with a strong regulatory framework (PMDA) and deep expertise in regenerative medicine. The country was the first to approve iPSC-derived cell therapies.

Biotech Market Cap
$306.9B
Public Companies
25
Total Companies
26
30D Performance
-5.54%

BIOTECH MARKET CAP INDEX

$306.9B+1922.3%ALL

BIOTECH HUBS

TokyoOsakaKobeTsukuba

COMPANIES

#CompanyValuation
1
Nipro Corporation
Nipro Corporation8086.T		$242.4B
2
Towa Pharmaceutical
Towa Pharmaceutical4553.T		$195.7B
3
Takara Bio
Takara Bio4974.T		$138.1B
4
Mochida Pharmaceutical
Mochida Pharmaceutical4534.T		$126.7B
5
Zeria Pharmaceutical
Zeria Pharmaceutical4559.T		$93.1B
6
Chugai Pharmaceutical
Chugai Pharmaceutical4519.T		$89.4B
7
JCR Pharmaceuticals
JCR Pharmaceuticals4552.T		$72.8B
8
Takeda Pharmaceutical
Takeda PharmaceuticalTAK		$56.3B
9
Otsuka Holdings
Otsuka Holdings4578.T		$35.5B
10
Daiichi Sankyo
Daiichi Sankyo4568.T		$33.4B
11
Astellas Pharma
Astellas Pharma4503.T		$26.8B
12
Shionogi
Shionogi4507.T		$18.0B
13
Eisai
Eisai4523.T		$8.4B
14
Kyowa Kirin
Kyowa Kirin4151.T		$7.7B
15
Ono Pharmaceutical
Ono Pharmaceutical4528.T		$6.9B
16
Sumitomo Pharma
Sumitomo Pharma4506.T		$4.6B
17
Santen Pharmaceutical
Santen Pharmaceutical4536.T		$3.4B
18
Rohto Pharmaceutical
Rohto Pharmaceutical4527.T		$3.3B
19
KOBAYASHI Pharmaceutical
KOBAYASHI Pharmaceutical4967.T		$2.6B
20
Nippon Shinyaku
Nippon Shinyaku4516.T		$2.1B
Showing 1–20 of 26 companies
Page 1 of 2
← Back to countries